Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex

F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery

(2012) Quanyin Hu et al.   BIOMATERIALS

The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells

(2012) Urszula Daniluk et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle

(2011) Jin Kyeoung Kim et al.   BIOMATERIALS

PMLRAR  binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo

(2011) R.-H. Tao et al.   BLOOD

Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type

(2011) Bernard Krust et al.   BMC CANCER

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Chimeric aptamers in cancer cell-targeted drug delivery

(2011) Jagat R. Kanwar et al.   CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Cutaneous T-Cell Lymphoma Cells and Enhance Their Sensitivity for TNF-Related Apoptosis-Inducing Ligand

(2011) Frank K. Braun et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Vascular targeted single-walled carbon nanotubes for near-infrared light therapy of cancer

(2011) Whitney M Prickett et al.   NANOTECHNOLOGY

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

(2011) Farnoosh Tayyari et al.   NATURE MEDICINE

Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation

(2011) Olga M. Shatnyeva et al.   PLoS One

Antibodies Against Nucleolin in Recipients of Organ Transplants

(2011) Zhiqiang Qin et al.   TRANSPLANTATION

Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice

(2010) Diala El Khoury et al.   BMC CANCER

Understanding rituximab function and resistance: implications for tailored therapy

(2010) Alfredo Amoroso   Frontiers in Bioscience-Landmark

Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach

(2009) Xiaohong Fang et al.   ACCOUNTS OF CHEMICAL RESEARCH

Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature

(2009) Valentina Fogal et al.   ANGIOGENESIS

Mechanism of Fas Signaling Regulation by Human Herpesvirus 8 K1 Oncoprotein

(2009) Z. Berkova et al.   JNCI-Journal of the National Cancer Institute

Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells

(2009) Enken Drecoll et al.   PLoS One

The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells

(2008) S. Soundararajan et al.   CANCER RESEARCH

Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells

(2008) E. Merit Reyes-Reyes et al.   EXPERIMENTAL CELL RESEARCH

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma

(2008) Lee Ridley et al.   NEURO-ONCOLOGY

Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin

(2008) Damien Destouches et al.   PLoS One